http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2529229-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b125aa300b2a4a2442697cba4bb19c8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2011-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c2ee08047cddcd0f53c57c4e8dbc088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0de1a6bf3a341d25074dbaa73387516e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca1453ae429e3917a800bdca11fd604c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9efbc114cfc348c29a0efe0f8486215f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b757eab56527ffc893bfd9a91b62e094 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7009c925cb79ccca1d46bd736deedc9 |
| publicationDate | 2012-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2529229-A1 |
| titleOfInvention | Diagnosing prostate cancer relapse |
| abstract | The invention discloses the use of at least one substance selected from the group consisting of Phosphatidylcholine with diacyl residue sum C24:0 (PC aa C24:0); Phosphatidylcholine with diacyl residue sum C40:3 (PC ae C40:3); Phosphatidylcholine with diacyl residue sum C40:4 (PC ae C40:4); Lysophosphatidylcholine with acyl residue sum C26:0 (lysoPC a C26:0); Lysophosphatidylcholine with acyl residue sum C6:0 (lysoPC a C6:0); 13(S)-hydroxy-9Z,11E-octadecadienoic acid (13S-HODE); 12(S)-hydroxy- 5Z, 8Z, 10E,14Z-eicosatetraenoic acid (12S-HETE); 15(S)-hydroxy- 5Z, 8Z, 11Z, 13E-eicosatetraenoic acid (15S-HETE); Leukotriene B4 (LTB4); Prostaglandin E2 (PGE2); Prostaglandin D2 (PGD2); 7α- Hydroxycholesterol (7aOHC); 7-Ketocholesterol (7KC); 5β, 6β- Epoxycholesterol (5b,6b,EPC); 5g302,6g302-Epoxycholesterol (5a, 6a, EPC); and 4β-Hydroxycholesterol (4BOHC); for prognosticating relapse of a prostate cancer (PCa) in a sample of a body fluid or a tissue sample of a PCa patient. |
| priorityDate | 2010-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 665.